keyword
https://read.qxmd.com/read/38567809/do-clinical-guidelines-support-person-centred-care-for-women-affected-by-dementia-a-content-analysis
#21
JOURNAL ARTICLE
Nevetda Gengeswaran, Alec Brandwood, Natalie N Anderson, Jessica U Ramlakhan, Anna R Gagliardi
BACKGROUND: Dementia disproportionately affects women including persons living with dementia and caregivers. Person-centered care, rather than disease-focused, is recommended to improve care for affected persons including caregivers. General practitioners play a central role in dementia care but find it challenging due to inadequate training. The study aimed to assess if and how dementia guidelines provide clinicians with guidance on person-centred care for women affected by dementia...
April 3, 2024: Dementia
https://read.qxmd.com/read/38567389/effect-of-digital-technology-interventions-for-cognitive-function-improvement-in-mild-cognitive-impairment-and-dementia-a-systematic-review-and-meta-analysis
#22
JOURNAL ARTICLE
Hyojin Park, Juyoung Ha
The development and commercialization of digital therapeutics are increasing. The aim of this study was to determine the effects of digital technology interventions on cognitive function, thereby providing evidence for the development and practical application of interventions to manage cognitive function in patients with mild cognitive impairment and dementia. We conducted a systematic review and meta-analysis of randomized controlled trials according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines...
April 3, 2024: Research in Nursing & Health
https://read.qxmd.com/read/38566584/profiling-lecanemab-as-a-treatment-option-for-alzheimer-s-disease
#23
REVIEW
Emily R Schiller, Bret David Silverglate, George T Grossberg
INTRODUCTION: In July 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD dementia. Considering the limited treatment options for AD, the approval of lecanemab offers hope and opens the door for other disease-modifying therapies in the pipeline. AREAS COVERED: In this review, the authors summarize the FDA treatment guidelines, other anti-amyloid agents, and drug information relevant to prescribers, such as pharmacology and pharmacokinetics...
April 3, 2024: Expert Review of Neurotherapeutics
https://read.qxmd.com/read/38558630/addressing-the-unmet-needs-of-patients-with-rapidly-progressive-neurological-disease-a-case-report-of-palliative-care-in-creutzfeldt-jakob-disease-cjd
#24
Justin R Price, Raya E Kheirbek
Creutzfeldt-Jacob disease (CJD) is a rare neurodegenerative disorder that typically progresses rapidly and unrelentingly. Providing comfort and support for patients with CJD presents significant challenges for clinicians and caregivers. In comparison to the more typical disease progression experienced in dementias, the trajectory of CJD differs significantly. This case report delves into these differences and emphasizes the need for the development of guidelines for healthcare professionals and families who care for individuals with CJD...
February 2024: Curēus
https://read.qxmd.com/read/38552471/nurse-led-physical-activity-interventions-for-people-with-dementia-in-nursing-homes-a-systematic-review-on-intervention-characteristics-and-implementation-facilitators-barriers
#25
JOURNAL ARTICLE
Julian Hirt, Janine Vetsch, Inga Weissenfels, Steffen Heinrich
BACKGROUND: Physical activities are important to maintain and promote physical functioning and activities of daily living in people with dementia. Nurses are in a key position to deliver physical activity interventions in nursing homes. However, synthesized strategies for sustainable implementation of physical activity interventions in nursing homes for people with dementia are lacking. OBJECTIVE: We aimed at synthesizing the evidence on nurse-led physical activity interventions and at identifying facilitators and barriers to sustainable implementation of physical activity interventions for people with dementia...
March 15, 2024: International Journal of Nursing Studies
https://read.qxmd.com/read/38552117/self-reported-late-life-hypertension-is-associated-with-a-healthy-cognitive-status-and-reduced-alzheimer-s-disease-pathology-burden
#26
JOURNAL ARTICLE
Andrew C Robinson, Tawfique Bin Rizwan, Yvonne S Davidson, James Minshull, Phillip Tinkler, Antony Payton, David M A Mann, Federico Roncaroli
BACKGROUND: While mid-life hypertension represents a risk factor for the development of Alzheimer's disease (AD), the risk after the age of 65 is less certain. Establishing relationships between late life hypertension and the pathological changes of AD could be crucial in understanding the relevance of blood pressure as a risk factor for this disorder. OBJECTIVE: We investigated associations between self-reported late-life hypertension, cognitive status and AD pathology at death...
March 25, 2024: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/38551155/patient-reported-outcome-measures-for-monitoring-primary-care-patients-with-depression-the-promdep-cluster-rct-and-economic-evaluation
#27
JOURNAL ARTICLE
Tony Kendrick, Christopher Dowrick, Glyn Lewis, Michael Moore, Geraldine M Leydon, Adam Wa Geraghty, Gareth Griffiths, Shihua Zhu, Guiqing Lily Yao, Carl May, Mark Gabbay, Rachel Dewar-Haggart, Samantha Williams, Lien Bui, Natalie Thompson, Lauren Bridewell, Emilia Trapasso, Tasneem Patel, Molly McCarthy, Naila Khan, Helen Page, Emma Corcoran, Jane Sungmin Hahn, Molly Bird, Mekeda X Logan, Brian Chi Fung Ching, Riya Tiwari, Anna Hunt, Beth Stuart
BACKGROUND: Guidelines on the management of depression recommend that practitioners use patient-reported outcome measures for the follow-up monitoring of symptoms, but there is a lack of evidence of benefit in terms of patient outcomes. OBJECTIVE: To test using the Patient Health Questionnaire-9 questionnaire as a patient-reported outcome measure for monitoring depression, training practitioners in interpreting scores and giving patients feedback. DESIGN: Parallel-group, cluster-randomised superiority trial; 1 : 1 allocation to intervention and control...
March 2024: Health Technology Assessment: HTA
https://read.qxmd.com/read/38547903/-maccat-t-between-claim-and-practice-challenges-of-assessing-capacity-for-consent-in-dementia
#28
JOURNAL ARTICLE
Vasilija Rolfes, Uta Hinz, Heiner Fangerau, Dilara Voßberg, Martin Haupt
BACKGROUND: Consent is a prerequisite for medical diagnostic and therapeutic action. There is no standardised procedure for assessing the ability to give consent. The most widely used tool for structured assessment is the MacArthur Competence Assessment Tool for Treatment (MacCAT-T). OBJECTIVES:  People with dementia have impaired capacity to consent because of their disease. In order to answer the question to what extent structured assessment procedures can be usefully applied to people with dementia, we analyse the function, strengths and weaknesses of structured assessment procedures with a focus on the MacCAT-T and discuss suggestions for modification and further development of the tool...
March 28, 2024: Fortschritte der Neurologie-Psychiatrie
https://read.qxmd.com/read/38541988/pseudodementia-in-patients-with-unipolar-and-bipolar-disorders-a-case-series-and-literature-review
#29
REVIEW
Camilla Elefante, Giulio Emilio Brancati, Donatella Acierno, Gabriele Pistolesi, Sara Ricciardulli, Francesco Weiss, Francesca Romeo, Lorenzo Lattanzi, Icro Maremmani, Giulio Perugi
Even though pseudodementia has been historically linked to depression, other psychiatric conditions may cause reversible cognitive alterations. The purpose of this study is to improve our understanding of pseudodementia occurring throughout the entire bipolar spectrum. A systematic review was conducted according to PRISMA guidelines. PubMed, Scopus, and Web of Science databases were searched up to March 2023. Fifteen articles on patients with pseudodementia and bipolar disorder (BD), mania, hypomania, or mixed depression have been included...
March 19, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38541362/association-between-the-composition-of-drinking-water-and-cognitive-function-in-the-elderly-a-systematic-review
#30
REVIEW
Annie Wasick, Yeonsoo Kim
The prevalence of dementia increases with nearly 10 million new cases each year, with Alzheimer's disease contributing to 60-70% of cases. Environmental factors such as drinking water have been evaluated to determine if a relationship exists between trace elements in drinking water and the risk of developing cognitive disorders in the elderly. The purpose of the current systematic review was to evaluate an association between the composition of drinking water and cognitive function in the elderly. In accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines, a literature search was conducted using PubMed and CINAHL databases...
March 19, 2024: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/38539666/cognitive-emotional-and-daily-functioning-domains-involved-in-decision-making-among-patients-with-mild-cognitive-impairment-a-systematic-review
#31
REVIEW
Federica Alfeo, Tiziana Lanciano, Chiara Abbatantuono, Giorgia Gintili, Maria Fara De Caro, Antonietta Curci, Paolo Taurisano
Mild cognitive impairment (MCI) is a transitional or prodromal stage of dementia in which autonomies are largely preserved (autonomies are not particularly affected). However, this condition may entail a depletion of decision-making (DM) abilities likely due to a gradual deterioration of the prefrontal cortex and subcortical brain areas underlying cognitive-emotional processing. Given the clinical implications of a decline in self-determination observed in some MCI sufferers, the present systematic review was aimed at investigating the literature addressing DM processes in patients with MCI, consistent with PRISMA guidelines...
March 14, 2024: Brain Sciences
https://read.qxmd.com/read/38536448/arterial-spin-labelling-magnetic-resonance-imaging-and-perfusion-patterns-in-neurocognitive-and-other-mental-disorders-a-systematic-review
#32
REVIEW
Rita Ferreira, António J Bastos-Leite
We reviewed 33 original research studies assessing brain perfusion, using consensus guidelines from a "white paper" issued by the International Society for Magnetic Resonance in Medicine Perfusion Study Group and the European Cooperation in Science and Technology Action BM1103 ("Arterial Spin Labelling Initiative in Dementia"; https://www.cost.eu/actions/BM1103/ ). The studies were published between 2011 and 2023 and included participants with subjective cognitive decline plus; neurocognitive disorders, including mild cognitive impairment (MCI), Alzheimer's disease (AD), frontotemporal lobar degeneration (FTLD), dementia with Lewy bodies (DLB) and vascular cognitive impairment (VCI); as well as schizophrenia spectrum disorders, bipolar and major depressive disorders, autism spectrum disorder, attention-deficit/hyperactivity disorder, panic disorder and alcohol use disorder...
March 27, 2024: Neuroradiology
https://read.qxmd.com/read/38532522/donepezil-induced-bradycardia-in-a-schizophrenic-patient-with-comorbid-neurocognitive-disorder-a-case-report-and-review-of-the%C3%A2-literature
#33
JOURNAL ARTICLE
Nkolika Odenigbo, Stanley Nkemjika, Ayodele Atolagbe, Christian Nwabueze, Connie Olwit, Jeffery Lawrence, Tolulope Olupona
BACKGROUND: Trials of cholinergic and glutamatergic agents have improved cognition and memory for the geriatric schizophrenic population. Donepezil is an acetylcholinesterase inhibitor that improves cognition by preventing postsynaptic degradation of hippocampal acetylcholine in patients with mild-to-moderate dementia. Donepezil has been attributed to some adverse effects, especially gastrointestinal symptoms. However, cardiovascular adverse effects are not common as there remains a dearth of literature regarding donepezil-induced bradycardia...
March 27, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38530578/a-systematic-review-of-goal-attainment-scaling-implementation-practices-by-caregivers-in-randomized-controlled-trials
#34
REVIEW
Kulpreet Cheema, Taylor Dunn, Chere Chapman, Kenneth Rockwood, Susan E Howlett, Gunes Sevinc
BACKGROUND: Goal attainment scaling (GAS), an established individualized, patient-centred outcome measure, is used to capture the patient's voice. Although first introduced ~60 years ago, there are few published guidelines for implementing GAS, and almost none for its use when caregivers GAS is implemented with caregiver input. We conducted a systematic review of studies that implemented GAS with caregiver input; and examined variations in GAS implementation, analysis, and reporting. METHODS: Literature was retrieved from Medline, Embase, Cochrane, PsycInfo and CINAHL databases...
March 26, 2024: Journal of Patient-Reported Outcomes
https://read.qxmd.com/read/38528439/-we-had-conversations-we-wouldn-t-have-had-otherwise-exploring-home-dwelling-people-with-dementia-and-family-members-experiences-of-deliberating-on-ethical-issues-in-a-literature-based-intervention
#35
JOURNAL ARTICLE
Sofie Smedegaard Skov, Marie Eva Berg, Josefine Ranfelt Andersen, Frederik Schou-Juul, Anja M B Jensen, Anna Paldam Folker, Sigurd Lauridsen
AIM: To explore home-dwelling people with dementia and family members' perceptions of the feasibility and acceptability of an intervention using dementia-related literature excerpts to facilitate conversations on ethical issues related to living with dementia. BACKGROUND: Ethical issues in dementia care emerge throughout the illness. In the early stages, they may involve decisions about disclosing the illness to the family, shifting roles and responsibilities, and considerations of transitioning to a nursing home...
March 25, 2024: Journal of Clinical Nursing
https://read.qxmd.com/read/38525806/perspectives-on-approaching-pain-management-in-patients-with-dementia
#36
REVIEW
Lisa Attrill, Pat Schofield
This paper presents a review of the latest literature and guidance regarding the assessment and management of pain in older adults with dementia. The size and nature of the problem will be presented, in terms of the increasing aging population across the globe and potential for a significant increase in adults with dementia, along with the reduction in younger counterparts who will be available to provide care in the future. We will present the latest recommendations regarding how to assess pain and which tools are recommended for use underpinned by the strongest evidence...
March 25, 2024: Pain Management
https://read.qxmd.com/read/38519775/association-between-mediterranean-diet-and-dementia-and-alzheimer-disease-a-systematic-review-with-meta-analysis
#37
REVIEW
Daniele Nucci, Andrea Sommariva, Luca Mario Degoni, Giulia Gallo, Matteo Mancarella, Federica Natarelli, Antonella Savoia, Alessandro Catalini, Roberta Ferranti, Fabrizio Ernesto Pregliasco, Silvana Castaldi, Vincenza Gianfredi
BACKGROUND: Dementia affects 5-8% of the population aged over 65 years (~50 million worldwide). Several factors are associated with increased risk, including diet. The Mediterranean diet (MedDiet) has shown potential protective effects against several chronic diseases. AIMS: This systematic review with meta-analysis aim was to assess the association between adherence to the MedDiet and the risk of dementia in the elderly. METHODS: PRISMA-2020 guidelines were followed...
March 22, 2024: Aging Clinical and Experimental Research
https://read.qxmd.com/read/38517586/the-role-of-123-i-mibg-cardiac-scintigraphy-in-the-differential-diagnosis-between-dementia-with-lewy-bodies-and-alzheimer-s-disease
#38
REVIEW
Giacomo Monzio Compagnoni, Ildebrando Appollonio, Carlo Ferrarese
Although detailed diagnostic guidelines are available, differentiating dementia with Lewy bodies from Alzheimer's disease is often difficult. 123-I-MIBG cardiac scintigraphy is one of the tools which have been proposed for the diagnostic procedure. The present review is aimed at evaluating the available literature about this topic. Studies assessing the use of this technique to differentiate between the two diseases have been examined and reported. Overall, despite a certain study-to-study variability, the available literature suggests that 123-I-MIBG cardiac scintigraphy is an effective tool in differentiating between the two diseases, with high sensitivity and specificity values...
March 22, 2024: Neurological Sciences
https://read.qxmd.com/read/38515049/noninvasive-monitoring-technologies-to-identify-discomfort-and-distressing-symptoms-in-persons-with-limited-communication-at-the-end-of-life-a-scoping-review
#39
JOURNAL ARTICLE
Jingyuan Xu, Hanneke J A Smaling, Jan W Schoones, Wilco P Achterberg, Jenny T van der Steen
BACKGROUND: Discomfort and distressing symptoms are common at the end of life, while people in this stage are often no longer able to express themselves. Technologies may aid clinicians in detecting and treating these symptoms to improve end-of-life care. This review provides an overview of noninvasive monitoring technologies that may be applied to persons with limited communication at the end of life to identify discomfort. METHODS: A systematic search was performed in nine databases, and experts were consulted...
March 21, 2024: BMC Palliative Care
https://read.qxmd.com/read/38503671/requesting-that-delirium-achieve-parity-with-acute-encephalopathy-in-the-ms-drg-system
#40
JOURNAL ARTICLE
Mark A Oldham, Thomas Heinrich, James Luccarelli
Since 2007, the Medicare Severity Diagnosis Related Groups classification system has favored billing codes for acute encephalopathy over delirium codes in determining hospital reimbursement and several quality-of-care value metrics, despite broad overlap between these sets of diagnostic codes. Toxic and metabolic encephalopathy codes are designated as major complication or comorbidity, whereas causally specified delirium codes are designated as complication or comorbidity and thus associated with a lower reimbursement and lesser impact on value metrics...
February 22, 2024: Journal of the Academy of Consultation—Liaison Psychiatry
keyword
keyword
71577
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.